World rank, 2022-now #9,113
of 22,385 · #7,316 all time
Rank in Switzerland #66
of 186 Research works 687
▲ 125% vs 2018-21
Citations 7.7k 11.2 per fractional work
Top-10% rate 9.4%
all institutions 10.0%
vs its own fields 0.98×
1.00× is exactly expected
Open access 53%
world 40%
International 60%
world 18%
What is Alexion Pharma (Switzerland) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
Field World rank Where that sits Top-10% rate Works All time Domain #5,204 of 9,902 11.5% 91
#5527 Field #4,745 of 8,541 10.6% 76
#4812
Which fields of science does Alexion Pharma (Switzerland) work in?
In 2022-now, 44% of research at Alexion Pharma (Switzerland) is in Health Sciences , 22% in Life Sciences . Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (9%), Social Sciences (7%). It does 1.8× the world's share of Health Sciences.
Health Sciences: 114 fractional works · 43.5% of its work Medicine: 95 fractional works · 36.4% of its work Surgery: 12 fractional works · 4.5% of its work Neurology: 9 fractional works · 3.6% of its work Physiology: 6 fractional works · 2.4% of its work Oncology: 6 fractional works · 2.2% of its work Public Health, Environmental and Occupational Health: 6 fractional works · 2.1% of its work Pulmonary and Respiratory Medicine: 5 fractional works · 1.9% of its work Pathology and Forensic Medicine: 5 fractional works · 1.9% of its work Radiology, Nuclear Medicine and Imaging: 4 fractional works · 1.7% of its work Nephrology: 4 fractional works · 1.5% of its work Epidemiology: 4 fractional works · 1.4% of its work Hematology: 3 fractional works · 1.2% of its work Endocrinology, Diabetes and Metabolism: 3 fractional works · 1.2% of its work Cardiology and Cardiovascular Medicine: 3 fractional works · 1.1% of its work Infectious Diseases: 3 fractional works · 1.1% of its work Rheumatology: 2 fractional works · 0.9% of its work Psychiatry and Mental health: 2 fractional works · 0.9% of its work Orthopedics and Sports Medicine: 2 fractional works · 0.7% of its work Genetics: 2 fractional works · 0.7% of its work Ophthalmology: 2 fractional works · 0.7% of its work Pharmacology: 2 fractional works · 0.6% of its work Pediatrics, Perinatology and Child Health: 2 fractional works · 0.6% of its work Urology: 1 fractional works · 0.5% of its work Complementary and alternative medicine: 1 fractional works · 0.5% of its work Transplantation: 1 fractional works · 0.3% of its work Gastroenterology: 1 fractional works · 0.2% of its work Obstetrics and Gynecology: 1 fractional works · 0.2% of its work Hepatology: 1 fractional works · 0.2% of its work Rehabilitation: 1 fractional works · 0.2% of its work Reproductive Medicine: 1 fractional works · 0.2% of its work Critical Care and Intensive Care Medicine: 1 fractional works · 0.2% of its work Smaller subfields together: 2 fractional works · 0.8% of its work Dentistry: 8 fractional works · 3.2% of its work Oral Surgery: 3 fractional works · 1.3% of its work Orthodontics: 3 fractional works · 1.1% of its work Periodontics: 1 fractional works · 0.5% of its work Smaller subfields together: 0 fractional works · 0.2% of its work Health Professions: 6 fractional works · 2.5% of its work General Health Professions: 3 fractional works · 1.3% of its work Emergency Medical Services: 1 fractional works · 0.2% of its work Smaller subfields together: 3 fractional works · 1.0% of its work Nursing: 3 fractional works · 1.1% of its work Nutrition and Dietetics: 2 fractional works · 0.9% of its work Smaller subfields together: 0 fractional works · 0.2% of its work Veterinary: 1 fractional works · 0.4% of its work Small Animals: 1 fractional works · 0.4% of its work Smaller subfields together: 0 fractional works · 0.0% of its work Life Sciences: 57 fractional works · 21.8% of its work Biochemistry, Genetics and Molecular Biology: 23 fractional works · 8.8% of its work Molecular Biology: 11 fractional works · 4.3% of its work Genetics: 5 fractional works · 2.0% of its work Biotechnology: 2 fractional works · 0.7% of its work Physiology: 2 fractional works · 0.6% of its work Cancer Research: 1 fractional works · 0.3% of its work Endocrinology: 1 fractional works · 0.3% of its work Cell Biology: 1 fractional works · 0.3% of its work Smaller subfields together: 1 fractional works · 0.3% of its work Agricultural and Biological Sciences: 17 fractional works · 6.7% of its work Plant Science: 5 fractional works · 1.8% of its work Animal Science and Zoology: 4 fractional works · 1.5% of its work Food Science: 3 fractional works · 1.0% of its work General Agricultural and Biological Sciences: 2 fractional works · 0.7% of its work Insect Science: 1 fractional works · 0.5% of its work Ecology, Evolution, Behavior and Systematics: 1 fractional works · 0.5% of its work Soil Science: 1 fractional works · 0.3% of its work Agronomy and Crop Science: 1 fractional works · 0.2% of its work Smaller subfields together: 0 fractional works · 0.1% of its work Immunology and Microbiology: 9 fractional works · 3.5% of its work Immunology: 5 fractional works · 2.1% of its work Parasitology: 3 fractional works · 1.1% of its work Smaller subfields together: 1 fractional works · 0.3% of its work Neuroscience: 6 fractional works · 2.2% of its work Cognitive Neuroscience: 2 fractional works · 0.9% of its work Neurology: 2 fractional works · 0.6% of its work Cellular and Molecular Neuroscience: 1 fractional works · 0.3% of its work Smaller subfields together: 1 fractional works · 0.4% of its work Pharmacology, Toxicology and Pharmaceutics: 2 fractional works · 0.7% of its work Pharmaceutical Science: 1 fractional works · 0.3% of its work Pharmacology: 1 fractional works · 0.2% of its work Smaller subfields together: 0 fractional works · 0.2% of its work Social Sciences: 49 fractional works · 18.8% of its work Social Sciences: 19 fractional works · 7.3% of its work Sociology and Political Science: 7 fractional works · 2.6% of its work Political Science and International Relations: 3 fractional works · 1.2% of its work Law: 3 fractional works · 1.1% of its work Transportation: 1 fractional works · 0.5% of its work Demography: 1 fractional works · 0.3% of its work Gender Studies: 1 fractional works · 0.3% of its work Health: 1 fractional works · 0.2% of its work Smaller subfields together: 3 fractional works · 1.0% of its work Economics, Econometrics and Finance: 9 fractional works · 3.5% of its work Economics and Econometrics: 6 fractional works · 2.3% of its work General Economics, Econometrics and Finance: 2 fractional works · 0.9% of its work Finance: 1 fractional works · 0.3% of its work Psychology: 9 fractional works · 3.4% of its work Clinical Psychology: 4 fractional works · 1.5% of its work Experimental and Cognitive Psychology: 3 fractional works · 1.0% of its work Social Psychology: 1 fractional works · 0.6% of its work Developmental and Educational Psychology: 1 fractional works · 0.3% of its work Smaller subfields together: 0 fractional works · 0.1% of its work Business, Management and Accounting: 6 fractional works · 2.3% of its work Strategy and Management: 2 fractional works · 0.9% of its work Accounting: 1 fractional works · 0.5% of its work Management Information Systems: 1 fractional works · 0.5% of its work Organizational Behavior and Human Resource Management: 1 fractional works · 0.3% of its work Smaller subfields together: 0 fractional works · 0.0% of its work Arts and Humanities: 5 fractional works · 2.1% of its work Philosophy: 1 fractional works · 0.5% of its work Literature and Literary Theory: 1 fractional works · 0.3% of its work Visual Arts and Performing Arts: 1 fractional works · 0.3% of its work Museology: 1 fractional works · 0.3% of its work Archeology: 1 fractional works · 0.3% of its work Smaller subfields together: 1 fractional works · 0.3% of its work Decision Sciences: 0 fractional works · 0.2% of its work Physical Sciences: 41 fractional works · 15.9% of its work Engineering: 14 fractional works · 5.5% of its work Building and Construction: 3 fractional works · 1.0% of its work Biomedical Engineering: 2 fractional works · 1.0% of its work Civil and Structural Engineering: 2 fractional works · 0.9% of its work Aerospace Engineering: 2 fractional works · 0.6% of its work Electrical and Electronic Engineering: 1 fractional works · 0.6% of its work Safety, Risk, Reliability and Quality: 1 fractional works · 0.5% of its work Mechanical Engineering: 1 fractional works · 0.5% of its work Control and Systems Engineering: 1 fractional works · 0.3% of its work Smaller subfields together: 1 fractional works · 0.2% of its work Computer Science: 12 fractional works · 4.6% of its work Artificial Intelligence: 4 fractional works · 1.6% of its work Computational Theory and Mathematics: 3 fractional works · 1.0% of its work Computer Networks and Communications: 2 fractional works · 0.6% of its work Information Systems: 1 fractional works · 0.6% of its work Signal Processing: 1 fractional works · 0.4% of its work Smaller subfields together: 1 fractional works · 0.5% of its work Environmental Science: 7 fractional works · 2.8% of its work Ecology: 2 fractional works · 0.7% of its work Water Science and Technology: 2 fractional works · 0.6% of its work Health, Toxicology and Mutagenesis: 1 fractional works · 0.4% of its work Industrial and Manufacturing Engineering: 1 fractional works · 0.4% of its work Management, Monitoring, Policy and Law: 1 fractional works · 0.2% of its work Smaller subfields together: 2 fractional works · 0.6% of its work Materials Science: 3 fractional works · 1.0% of its work Materials Chemistry: 1 fractional works · 0.6% of its work Biomaterials: 1 fractional works · 0.4% of its work Smaller subfields together: 0 fractional works · 0.0% of its work Chemistry: 2 fractional works · 0.6% of its work Organic Chemistry: 1 fractional works · 0.3% of its work Analytical Chemistry: 1 fractional works · 0.2% of its work Smaller subfields together: 0 fractional works · 0.1% of its work Physics and Astronomy: 1 fractional works · 0.5% of its work Atomic and Molecular Physics, and Optics: 1 fractional works · 0.2% of its work Smaller subfields together: 1 fractional works · 0.2% of its work Energy: 1 fractional works · 0.3% of its work Energy Engineering and Power Technology: 1 fractional works · 0.2% of its work Smaller subfields together: 0 fractional works · 0.1% of its work Mathematics: 1 fractional works · 0.2% of its work Statistics and Probability: 1 fractional works · 0.2% of its work Earth and Planetary Sciences: 0 fractional works · 0.2% of its work Chemical Engineering: 0 fractional works · 0.0% of its work Health Sciences Medicine Dentistry Health Pr… Life Sciences Biochemistry Agricultu… Immunolog… Neuroscie… Social Sciences Social Sciences Economics Psychology Business Arts and… Physical Sciences Engineeri… Computer… Environme… ALL ITS WORK Alexion Pharma (Switzerland) 261 fractional works, 2022-now 22% 16% 44% 19%
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers 95 36.4% 8 3.2% 6 2.5% 3 1.1% 1 0.4% 23 8.8% 17 6.7% 9 3.5% 6 2.2% 2 0.7% 19 7.3% 9 3.5% 9 3.4% 6 2.3% 5 2.1% 0 0.2% 14 5.5% 12 4.6% 7 2.8% 3 1.0% 2 0.6% 1 0.5% 1 0.3% 1 0.2% 0 0.2% 0 0.0% All of science, and how each field's share has moved since 1950: the Science domain explorer
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Agricultural and Biological Sciences: 1.41× its world share, 18 works Agricultural and Bio… Biochemistry, Genetics and Molecular Biology: 1.65× its world share, 23 works Biochemistry, Geneti… Immunology and Microbiology: 3.44× its world share, 9 works Immunology and Micro… Neuroscience: 1.35× its world share, 6 works Neuroscience Pharmacology, Toxicology and Pharmaceutics: 1.94× its world share, 2 works Pharmacology, Toxico… Chemical Engineering: 0.12× its world share, 0 works Chemical Engineering Chemistry: 0.39× its world share, 2 works Chemistry Computer Science: 0.60× its world share, 12 works Computer Science Earth and Planetary Sciences: 0.11× its world share, 0 works Earth and Planetary … Energy: 0.32× its world share, 1 works Energy Engineering: 0.37× its world share, 14 works Engineering Environmental Science: 0.57× its world share, 7 works Environmental Science Materials Science: 0.29× its world share, 3 works Materials Science Mathematics: 0.19× its world share, 1 works Mathematics Physics and Astronomy: 0.22× its world share, 1 works Physics and Astronomy Dentistry: 6.53× its world share, 8 works Dentistry Health Professions: 0.94× its world share, 6 works Health Professions Medicine: 1.89× its world share, 95 works Medicine Nursing: 2.15× its world share, 3 works Nursing Veterinary: 3.13× its world share, 1 works Veterinary Arts and Humanities: 0.73× its world share, 6 works Arts and Humanities Business, Management and Accounting: 0.71× its world share, 6 works Business, Management… Decision Sciences: 0.17× its world share, 0 works Decision Sciences Economics, Econometrics and Finance: 1.63× its world share, 9 works Economics, Econometr… Psychology: 1.12× its world share, 9 works Psychology Social Sciences: 0.58× its world share, 19 works Social Sciences 1× world share
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry , 6.5×. Every wedge is a field page.
All 26 fields, with their numbers Dentistry 6.53× 8 works Immunology and Microbiology 3.44× 9 works Veterinary 3.13× 1 works Nursing 2.15× 3 works Pharmacology, Toxicology and Pharmaceutics 1.94× 2 works Medicine 1.89× 95 works Biochemistry, Genetics and Molecular Biology 1.65× 23 works Economics, Econometrics and Finance 1.63× 9 works Agricultural and Biological Sciences 1.41× 18 works Neuroscience 1.35× 6 works Psychology 1.12× 9 works Health Professions 0.94× 6 works Arts and Humanities 0.73× 6 works Business, Management and Accounting 0.71× 6 works Computer Science 0.60× 12 works Social Sciences 0.58× 19 works Environmental Science 0.57× 7 works Chemistry 0.39× 2 works Engineering 0.37× 14 works Energy 0.32× 1 works Materials Science 0.29× 3 works Physics and Astronomy 0.22× 1 works Mathematics 0.19× 1 works Decision Sciences 0.17× 0 works Chemical Engineering 0.12× 0 works Earth and Planetary Sciences 0.11× 0 works
Who are the top researchers at Alexion Pharma (Switzerland)?
Ranked on the quality score, Christoph Gasteyger , James Winkley and Philippe Gustovic lead among researchers whose main affiliation is Alexion Pharma (Switzerland).
1
Christoph Gasteyger
Switzerland · #1,517,021 worldwide1.8k citations · 50 works
2
James Winkley
Switzerland · #1,734,117 worldwide534 citations · 15 works
3
Philippe Gustovic
Switzerland · #2,645,875 worldwide134 citations · 20 works
4
Alessandro Zeppelli
Switzerland · #2,664,385 worldwide0 citations · 22 works
5
Christopher A. Scheiner
Switzerland · #4,153,202 worldwide203 citations · 16 works
6
Cory Williams
Switzerland · #4,583,178 worldwide91 citations · 18 works
7
Hesham
Switzerland · #5,000,454 worldwide28 citations · 23 works
All ranked researchers at Alexion Pharma (Switzerland)
What are the most cited papers from Alexion Pharma (Switzerland)?
The most cited paper from Alexion Pharma (Switzerland) is "Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial" (Christopher T. Ritchlin et al., 2014), with 664 citations. Next come "Predominant role for C5b-9 in renal ischemia/reperfusion injury" (466) and "Genetic Variants in C5 and Poor Response to Eculizumab" (417).
Most cited papers
# Paper Released Citations 1
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher T. Ritchlin et al. · Annals of the Rheumatic Diseases
Open access 30 Jan 2014
664 2
Predominant role for C5b-9 in renal ischemia/reperfusion injury
Wuding Zhou, Conrad A. Farrar, Katsushige Abe et al. · Journal of Clinical Investigation
Open access 15 May 2000
466 3
Genetic Variants in C5 and Poor Response to Eculizumab
Jun‐ichi Nishimura et al. · New England Journal of Medicine
Open access 12 Feb 2014
417 4
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion
Antti Väkevä, Azin Agah, Scott A. Rollins et al. · Circulation
9 Jun 1998
400 5
Development and Application of Cell-Based Biosensors
Joseph Jewell Pancrazio, James Whelan, David A. Borkholder et al. · Annals of Biomedical Engineering
Nov 1999
390
All 60 most cited papers, with filters and sorting
Which keywords describe research at Alexion Pharma (Switzerland)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology , Prognosis, Treatment, Quality of Life, Diagnosis, Autoantibodies, Clinical Trials and Genetics.
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers Epidemiology 21 ▲ 1.98× 76 topics Treatment 11 ▲ 3.4× 30 topics Quality of Life 11 ▲ 2.8× 32 topics Diagnosis 9 ▲ 3.7× 25 topics Inflammation 9 ▲ 1.63× 42 topics Prognosis 8 ▲ 9.6× 7 topics Oxidative Stress 7 ▲ 1.58× 35 topics Clinical Trials 6 ▲ 3.8× 14 topics Genetics 6 ▲ 3.5× 16 topics Public Health 6 ▲ 1.68× 23 topics Artificial Intelligence 6 ▲ 1.67× 12 topics Neurological Disorders 6 ▲ 4.0× 12 topics Autoantibodies 6 ▲ 9.3× 8 topics Immunotherapy 6 ▲ 2.9× 10 topics Obesity 5 ▲ 2.3× 11 topics Pathogenesis 5 ▲ 3.6× 14 topics Regulation 4 ▲ 2.9× 6 topics Innate Immunity 4 ▲ 4.7× 4 topics Cardiovascular Risk 4 ▲ 4.8× 8 topics Diagnostic Criteria 4 ▲ 6.4× 8 topics Ethical Issues 4 ▲ 13× 3 topics Legal Regulation 4 ▲ 6.3× 3 topics Neuromuscular Junction 4 ▲ 34× 2 topics Regenerative Medicine 4 ▲ 5.5× 5 topics Weight Loss 4 ▲ 8.6× 4 topics Myasthenia Gravis 4 ▲ 68× 1 topic Thymic Tumors 4 ▲ 68× 1 topic Regulatory Challenges 3 ▲ 14× 3 topics Inflammatory Diseases 3 ▲ 6.6× 3 topics Bioenergy 3 ▲ 22× 2 topics Complement 3 ▲ 66× 1 topic Immune 3 ▲ 66× 1 topic Monoclonal Antibodies 3 ▲ 13× 3 topics Innovation Policy 3 ▲ 11× 3 topics Blockchain Technology 3 ▲ 17× 2 topics Dietary Fiber 3 ▲ 9.3× 2 topics Intravenous Immunoglobulin 2 ▲ 15× 2 topics Economic Evaluation 2 ▲ 7.7× 2 topics Information Security 2 ▲ 9.5× 2 topics Genetic Information 2 ▲ 23× 1 topic
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they
sit on one scale and can be read against each other as well as against the world.
53% 47%
53.3% 46.7%
World: 40% of research is openly available.
60% 40%
60.0% 40.0%
World: 18% is written across borders.
How has Alexion Pharma (Switzerland)'s research output changed?
Output in 2022-2025 was 125% higher than in 2018-2021.
still counting 1990 2000 2010 2020
The same series as a ribbon: one cell per year, darker for more. The line above answers how much ; this answers when .
Its share of all research
still counting 0.00050% 0.0010% 0.0015% Alexion Pharma (Switzerland) 0.0013% in 2025 1980 1990 2000 2010 2020 Fractional works of Alexion Pharma (Switzerland) over all fractional works that year. How the balance of science has shifted .
How much of it reaches the world top 10%
still counting 10% 20% Alexion Pharma (Switzerland) 11.6% in 2025 all institutions 10.0% in 2025 2020 Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.3% in 2019.
Share Alexion Pharma (Switzerland)'s ranking
A card with Alexion Pharma (Switzerland)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.
Badges for a website 1 Each links back here and updates with every snapshot
Switzerland · #1,517,021 worldwide
1.8k citations · 50 works
